B Cell Lymphoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
T
Not yet recruiting
  • CART Treatment
  • B Cell Lymphoma
  • Tel-Aviv, Israel
    Tel-Aviv Sourasky Medicak center / BMT Unit
2022-04-05
Apr 5, 2022
C
Recruiting
  • Lymphoma, Non-Hodgkin
  • +6 more
  • CB-010
  • +2 more
  • Scottsdale, Arizona
  • +5 more
2022-04-05
Apr 5, 2022
B
Active, not recruiting
  • B Cell Lymphoma
  • Lymphoma
  • Cleveland, Ohio
  • +1 more
2022-03-03
Mar 3, 2022
S
Recruiting
  • B Cell Lymphoma
  • +2 more
  • Stanford, California
    Stanford Medical Center
2022-03-25
Mar 25, 2022
B
Active, not recruiting
  • B Cell Lymphoma
  • +2 more
  • Houston, Texas
  • +1 more
2022-02-10
Feb 10, 2022
S
Recruiting
  • B Cell Lymphoma
  • Beijing, Beijing, China
    Beijing Cancer Hospital
2021-12-31
Dec 31, 2021
B
Recruiting
  • Diffuse Large B Cell Lymphoma
  • +7 more
  • BR101801 (Phase Ia)
  • +2 more
  • Seoul, Korea, Republic of
  • +2 more
2021-11-19
Nov 19, 2021
C
Completed
  • Advanced Solid Tumor
  • B Cell Lymphoma
  • Brisbane, Queensland, Austria
    Mater Medical Centre
2021-10-15
Oct 15, 2021
C
Recruiting
  • B Cell Lymphoma
  • CD19 and CD22 targeted prime CAR- T cells
  • Kunming, Yunnnan, China
    920th Hospital of Joint Logistics Support Force
2021-07-30
Jul 30, 2021
U
Active, not recruiting
  • B Cell Lymphoma
  • Manchester, United Kingdom
  • +3 more
2021-07-26
Jul 26, 2021
A
Recruiting
  • Mantle Cell Lymphoma
  • B Cell Lymphoma
  • Duarte, California
  • +10 more
2021-07-19
Jul 19, 2021
Y
Recruiting
  • B Cell Lymphoma
  • B-cell Acute Lymphoblastic Leukemia
  • Anti-CD19 CAR-T Cells Injection
  • Kunming, Yunnan, China
    Kunming Yan'an Hospital
2021-05-12
May 12, 2021
N
Recruiting
  • B Cell Leukemia
  • +4 more
  • CAR-ITNK cells
  • Guangzhou, Guangdong, China
    Department of Hematology,Nanfang Hospital, Southern Medical Univ
2021-02-06
Feb 6, 2021
U
Recruiting
  • B Cell Lymphoma
  • +4 more
  • Chicago, Illinois
    The University of Chicago
2021-01-05
Jan 5, 2021
K
Active, not recruiting
  • B Cell Lymphoma
  • +5 more
  • CAR-CD19 T cell
  • +5 more
  • Wenzhou, Zhejiang, China
    First Affiliated Hospital of Wenzhou Medical University
2020-10-05
Oct 5, 2020
N
Completed
  • ALL
  • +4 more
  • Anti-Cluster of Differentiation (CD)19-Chimeric antigen receptor (CAR)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2020-08-14
Aug 14, 2020
F
Withdrawn
  • B Cell Lymphoma
  • CD19-targeting CAR T Cells infusion
  • Guangzhou, Guangdong, China
    Central laboratory in Fuda cancer hospital
2020-07-14
Jul 14, 2020
P
Completed
  • B-cell Chronic Lymphocytic Leukemia
  • +9 more
  • Stanford, California
  • +15 more
2020-05-14
May 14, 2020
U
Completed
  • B Cell Leukemia
  • B Cell Lymphoma
  • CART-19
  • Philadelphia, Pennsylvania
    CHOP - http://www.chop.edu/service/oncology/pediatric-cancer-res
2020-03-02
Mar 2, 2020
J
Terminated
  • B Cell Lymphoma
  • JHL1101
  • Rituximab
  • Taiyuan, Shanxi, China
  • +1 more
2020-01-06
Jan 6, 2020
i
Unknown status
  • B Cell Lymphoma
  • B Cell Leukemia
  • CD20-CD19 cCAR T cells
  • Chengdu, China
  • +1 more
2019-11-08
Nov 8, 2019
i
Unknown status
  • B Cell Lymphoma
  • B Cell Leukemia
  • CD19 CARvac T cells
  • Chengdu, China
  • +1 more
2019-11-08
Nov 8, 2019
W
Recruiting
  • Acute Lymphoblastic Leukemia
  • B Cell Lymphoma
  • Second generation humanized CAR-T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
2019-08-05
Aug 5, 2019
W
Recruiting
  • B Cell Lymphoma
  • Acute Lymphoblastic Leukemia
  • Third generation CAR-T cells
  • Wuhan, Hubei, China
    Union Hospital, Tongji Medical College, Huazhong University of S
2019-08-05
Aug 5, 2019
S
Unknown status
  • B Cell Lymphoma
  • CD20-directed CAR-T cells
  • Shanghai, China
    Shanghai Tongji Hospital, Tongji University School of Medicine
2019-07-25
Jul 25, 2019